Beta Wealth Group, Inc. Milestone Pharmaceuticals Inc. Transaction History
Beta Wealth Group, Inc.
- $189 Million
- Q1 2024
A detailed history of Beta Wealth Group, Inc. transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Beta Wealth Group, Inc. holds 14,127 shares of MIST stock, worth $18,647. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,127
Previous 14,127
-0.0%
Holding current value
$18,647
Previous $23,000
8.7%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding MIST
# of Institutions
47Shares Held
31.3MCall Options Held
3.3KPut Options Held
3.5K-
Black Rock Inc. New York, NY4.97MShares$6.56 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$4.3 Million0.09% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.86MShares$3.77 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.37MShares$3.13 Million2.21% of portfolio
-
Lion Point Capital, LP New York, NY2.3MShares$3.04 Million2.63% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $39.6M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...